FDA Grants Breakthrough Device Designation to Click Therapeutics’ CT-155 for Schizophrenia Treatment
Key Highlights FDA Breakthrough Device designation awarded to CT-155, a novel prescription digital therapeutic co-developed by Click Therapeutics and…
